GP Pharm SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:GP Pharm SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0482
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GP Pharm SA (GP Pharm) is a biopharmaceutical company that develops and markets injectables in the areas of oncology and urology. The company provides product portfolio such as injectable dosage forms for the treatment of advanced prostate cancer; nocturnal enuresis and central diabetes insipidus; endometriosis, women fertility and precocious puberty, among others. It provides products for acromegaly and gastro esophageal variceal bleed; acute hemorrhages of the upper gastro enteric tract; colorectal cancer; ovarian, lung, pancreas and metastatic breast cancers; and for preventing uterine atony following the infant delivery through caesarean section, among others. GP Pharm is developing its pre-clinical candidates in the areas of oncology, central nervous system disorders and musculoskeletal disorders. The company also offers contract development and contract manufacturing of pharmaceutical injectables for sterile drug products. The company has a manufacturing facility at Catalonia, Barcelona, and others. GP Pharm is headquartered in Barcelona, Spain.

GP Pharm SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GP Pharm SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
GP Pharm SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GP Pharm SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Hemispherx Biopharma Enters into Distribution Agreement with GP Pharm for Ampligen 10
Licensing Agreements 11
PharmaMar Enters into Licensing Agreement with GP Pharm for Politrate Leuprorelin 11
Hikma Pharma Enters into Licensing and Supply Agreement with GP Pharm 12
Lee’s Pharma Enters Into Licensing Agreement With GP Pharm For Leuprolide 13
Hikma Pharma Enters Into Licensing Agreement With GP Pharm For Lutrate 1 Month 14
GP Pharm SA – Key Competitors 15
GP Pharm SA – Key Employees 16
GP Pharm SA – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
GP Pharm SA, Pharmaceuticals & Healthcare, Key Facts 2
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GP Pharm SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GP Pharm SA, Deals By Therapy Area, 2012 to YTD 2018 8
GP Pharm SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hemispherx Biopharma Enters into Distribution Agreement with GP Pharm for Ampligen 10
PharmaMar Enters into Licensing Agreement with GP Pharm for Politrate Leuprorelin 11
Hikma Pharma Enters into Licensing and Supply Agreement with GP Pharm 12
Lee's Pharma Enters Into Licensing Agreement With GP Pharm For Leuprolide 13
Hikma Pharma Enters Into Licensing Agreement With GP Pharm For Lutrate 1 Month 14
GP Pharm SA, Key Competitors 15
GP Pharm SA, Key Employees 16
GP Pharm SA, Other Locations 17

List of Figures
GP Pharm SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GP Pharm SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[GP Pharm SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • United Orthopedic Corp (4129):医療機器:M&Aディール及び事業提携情報
    Summary United Orthopedic Corp (UOC) is a medical device company that designs, manufactures and distributes orthopedic implants and instrument sets. The company provides product categories such as knee replacement systems, hip replacement systems, and oncology products, among others. It offers hip r …
  • Damen Shipyards Group:企業の戦略・SWOT・財務情報
    Damen Shipyards Group - Strategy, SWOT and Corporate Finance Report Summary Damen Shipyards Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Rapiscan Systems, Inc.:戦略・SWOT・企業財務分析
    Rapiscan Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rapiscan Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nomura Research Institute Ltd (4307):企業の財務・戦略的SWOT分析
    Nomura Research Institute Ltd (4307) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Keyera Corp (KEY):石油・ガス:M&Aディール及び事業提携情報
    Summary Keyera Corp (Keyera) is a midstream oil and gas company. The company offers services such as processing, storage, transportation and marketing of oil and natural gas. It owns and operates raw gas gathering pipelines and processing plants, which collect and process raw natural gas, remove was …
  • Achaogen Inc (AKAO):製薬・医療:M&Aディール及び事業提携情報
    Summary Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel anti bacterials for the treatment of multi-drug resistant and gram-negative infections. The company offers plazomicin for the treatment of serious bacterial infections including urinary t …
  • JinkoSolar Holding Co Ltd (JKS):電力:M&Aディール及び事業提携情報
    Summary JinkoSolar Holding Co Ltd (JinkoSolar) is a manufacturer of solar products. The company is involved in manufacturing and marketing of solar power products such as silicon ingots, silicon wafers, solar modules, solar PV cells, and monocrystalline and multicrystalline photovoltaic (PV) panels. …
  • Shikoku Electric Power Co., Inc.:企業の戦略・SWOT・財務分析
    Shikoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Shikoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • NSK Ltd (6471):企業の財務・戦略的SWOT分析
    NSK Ltd (6471) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Save The Children Federation Inc:企業の戦略的SWOT分析
    Save The Children Federation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Biomerica Inc (BMRA):企業の製品パイプライン分析
    Summary Biomerica, Inc. (Biomerica) develops, manufactures, and markets medical diagnostic products used for the early detection and monitoring of chronic diseases and medical conditions. The company’s diagnostic test kits used to analyze blood, urine and fecal specimens of the patient to diagnose v …
  • Bharat Road Network Ltd (BRNL):企業の財務・戦略的SWOT分析
    Bharat Road Network Ltd (BRNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • CEL-SCI Corp (CVM):製薬・医療:M&Aディール及び事業提携情報
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • Leidos Holdings Inc:企業の戦略・SWOT・財務情報
    Leidos Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Leidos Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • C-Rad AB (CRAD B):企業の財務・戦略的SWOT分析
    Summary C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments . The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems . Its products include sentinel 4DCT, catalyst H …
  • Equifax Inc.:企業の戦略・SWOT・財務情報
    Equifax Inc. - Strategy, SWOT and Corporate Finance Report Summary Equifax Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Scottish and Southern Energy plc:企業の戦略・SWOT・財務情報
    Scottish and Southern Energy plc - Strategy, SWOT and Corporate Finance Report Summary Scottish and Southern Energy plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Ferroglobe PLC (GSM):企業の財務・戦略的SWOT分析
    Ferroglobe PLC (GSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bank Sepah:企業の戦略・SWOT・財務情報
    Bank Sepah - Strategy, SWOT and Corporate Finance Report Summary Bank Sepah - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Applied Genetic Technologies Corp (AGTC):医療機器:M&Aディール及び事業提携情報
    Summary Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as x-linked retinoschisis, achromatopsia, x-linked retinitis pi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆